オハイオにおける間質性肺疾患の臨床試験
オハイオ内の拠点で、間質性肺疾患に関する14件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University Hospitals Cleveland Medical Center, Cleveland
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07540988Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA015, Cincinnati
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Cincinnati Department of Internal Medicine Pulmonary, Critical Care & Sleep Medicine, Cincinnati
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/29更新 · NCT05798923A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Cincinnati
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Cincinnati Medical Center, Cincinnati
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University Hospitals Cleveland Medical Center, Cleveland
被験者募集中
18歳以上 · 全性別 · 2026/09/02更新 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Cincinnati Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- The Cleveland Clinic, Cleveland
- 他1件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/26更新 · NCT06388421Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Cleveland Clinic, Cleveland
- The Ohio State University, Columbus
被験者募集中観察研究
21歳以上 · 全性別 · 2026/08/12更新 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Ohio State University, Columbus
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/08/10更新 · NCT07175038Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中第2相
4歳以上 · 全性別 · 2026/07/22更新 · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University of Cincinnati Medical Center, Cincinnati
- St. Luke's Univeristy Health Network-Pulmonary & Critical Care, Cincinnati
- The Ohio State University Wexner Medical CEnter, Columbus
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/13更新 · NCT05943535TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中観察研究
24歳以下 · 全性別 · 2026/06/22更新 · NCT04098445A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- GSK Investigational Site, Columbus
被験者募集中第1相健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2026/06/22更新 · NCT06576271Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Cleveland
被験者募集中第2相
18歳以上 · 全性別 · 2025/05/07更新 · NCT05892614ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。